Kirr Marbach & Co’s PURE BIOSCIENCE INC COM STK NEW (DE) PURE Stock Holding History

Kirr Marbach & Co’s Portfolio PURE Stock Details PURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,830	Closed	-$3K	–	63
2021 Q4	$3K	Hold	13,830	–	–	﹤0.01%	59
2021 Q3	$5K	Hold	13,830	–	–	﹤0.01%	59
2021 Q2	$6K	Hold	13,830	–	–	﹤0.01%	59
2021 Q1	$10K	Buy	+13,830	New	+$10K	﹤0.01%	59
2020 Q4	–	Sell	-13,830	Closed	-$24K	–	56
2020 Q3	$24K	Hold	13,830	–	–	0.01%	56
2020 Q2	$25K	Buy	+13,830	New	+$25K	0.01%	57
2014 Q4	–	Sell	-12,505	Closed	-$13K	–	66
2014 Q3	$13K	Hold	12,505	–	–	﹤0.01%	60
2014 Q2	$13K	Hold	12,505	–	–	﹤0.01%	58
2014 Q1	$16K	Buy	+12,505	New	+$16K	﹤0.01%	62

Kirr Marbach & Co's PURE Position: Q1 2022 in Review

Kirr Marbach & Co sold out of PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) in Q1 2022, closing a stake of 13,830 shares — an estimated $3K sold.

Kirr Marbach & Co first reported a position in PURE in Q1 2014 and held it in 9 quarters. The position peaked at $25K in Q2 2020. 0 funds tracked by Wall St. Rank hold PURE as of Q1 2022.

Kirr Marbach & Co reported no remaining PURE BIOSCIENCE INC COM STK NEW (DE) position as of Q1 2022 after selling out during the quarter.
Kirr Marbach & Co sold 13,830 PURE BIOSCIENCE INC COM STK NEW (DE) shares in Q1 2022, an estimated $3K.
Kirr Marbach & Co first reported a position in PURE BIOSCIENCE INC COM STK NEW (DE) in Q1 2014 and held it in 9 quarters.
Kirr Marbach & Co's PURE BIOSCIENCE INC COM STK NEW (DE) position peaked at $25K in Q2 2020.
0 funds tracked by Wall St. Rank held PURE BIOSCIENCE INC COM STK NEW (DE) as of Q1 2022.

Based on Kirr Marbach & Co's 13F filing for Q1 2022, filed 3 May 2022.